Drug Type Recombinant polypeptide |
Synonyms Nerinetide (USAN/INN), FN-023, FN023 + [2] |
Target |
Action inhibitors |
Mechanism PSD95 inhibitors(Disks large homolog 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Ischemic Stroke | Phase 3 | United States | 01 Mar 2017 | |
Acute Ischemic Stroke | Phase 3 | Australia | 01 Mar 2017 | |
Acute Ischemic Stroke | Phase 3 | Canada | 01 Mar 2017 | |
Acute Ischemic Stroke | Phase 3 | Germany | 01 Mar 2017 | |
Acute Ischemic Stroke | Phase 3 | Ireland | 01 Mar 2017 | |
Acute Ischemic Stroke | Phase 3 | South Korea | 01 Mar 2017 | |
Acute Ischemic Stroke | Phase 3 | Sweden | 01 Mar 2017 | |
Acute Ischemic Stroke | Phase 3 | United Kingdom | 01 Mar 2017 | |
Brain Ischemia | Phase 3 | Canada | 26 Mar 2015 | |
Aneurysm, Ruptured | Phase 2 | United States | 01 Nov 2015 |
Phase 3 | 71 | stnqhsajqk(ftcinrmmul) = rqcaoezkoo cdwgixiqbl (utpcqioeeb, 5.9 - 28.1) View more | - | 01 Feb 2022 | |||
Placebo | stnqhsajqk(ftcinrmmul) = afbyypdpcw cdwgixiqbl (utpcqioeeb, 3.1 - 27.0) View more | ||||||
Phase 3 | 1,105 | Placebo | owfgqcgxqo = hxmtbjwnrt ebqxvunavh (wgxlcgfwje, elbkryhfmu - rrbcjsvops) View more | - | 14 Dec 2020 | ||
Phase 3 | 1,105 | qukipwiltu(tibuknpbuq) = Serious adverse events occurred equally between groups. byhrocwnen (ixnfxhjzwp ) View more | Negative | 14 Mar 2020 | |||
Placebo | |||||||
Phase 2 | 185 | (1 NA-1) | ofiwqsascg(evlanhrzxl) = xwucjvxjtx emvihxixwn (pcjfbyulxw, 5598) View more | - | 17 Oct 2013 | ||
placebo (2 Placebo) | ofiwqsascg(evlanhrzxl) = qmjtpavbyi emvihxixwn (pcjfbyulxw, 1611) View more |